Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine.
Baumann
M H
MH
Clinical Psychopharmacology Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Pablo
J
J
Ali
S F
SF
Rothman
R B
RB
Mash
D C
DC
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D003345:Corticosterone / Q000097:blood; D004298:Dopamine / Q000502:physiology; D006801:Humans; D007050:Ibogaine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000633:toxicity; D009293:Opioid-Related Disorders / Q000188:drug therapy; D012701:Serotonin / Q000502:physiology
D012701:Serotonin; D007050:Ibogaine; C094385:noribogaine; D004298:Dopamine; D003345:Corticosterone